Establishment of a screening cell model for cannabinoid type 1 receptor agonists
10.16438/j.0513-4870.2022-1006
- VernacularTitle:建立大麻素1型受体激动剂的细胞筛选模型
- Author:
Xiao-tong WANG
;
Cheng-lu ZHANG
;
Ru-xue BO
;
Shi-qi ZHOU
;
Nai-hong CHEN
;
Yu-he YUAN
- Publication Type:Research Article
- Keywords:
cannabinoid type 1 receptor;
cell model;
cannabinoid 1 receptor agonist;
rug screening;
circular-permutated enhanced green fluorescent protein
- From:
Acta Pharmaceutica Sinica
2023;57(6):1603-1610
- CountryChina
- Language:Chinese
-
Abstract:
Cannabinoid receptors are one of the most expressed G protein-coupled receptors in the central nervous system, which are potential drug targets for inflammation, pain and drug abuse. Cannabinoid receptors are composed of type 1 receptor (CB1R), type 2 receptor (CB2R) and other receptors, of which CB1R plays a vital role in regulating central memory, cognition, and motor function. Therefore, screening CB1R agonists has potential value in treating nervous system diseases. In this study, the intracellular loop 3 (ICL3) domain of CB1R was replaced with a circular-permutated enhanced green fluorescent protein (cpEGFP). After infecting HEK 293T cells with lentivirus particles, we obtained a stable cell line that was overexpressed human CB1R-cpEGFP after puromycin selection. The interaction between receptor agonists and CB1R led to the change of receptor conformation, resulting in de-protonation of the EGFP, and enhancing the fluorescence intensity. Therefore, active CB1R compounds could be verified by measuring the fluorescence intensity. Using CB1R agonist arachidonyl-2′-chloroethylamide (ACEA) as a positive control to evaluate the reliability of this model, studies have shown that ACEA could induce receptor activation and increase fluorescence intensity, while antagonist rimonabant inhibited receptor activation with unchanged fluorescence intensity. In conclusion, this study successfully constructed a fluorescent probe screening model for CB1R agonists.
